Cargando…
Striatal Afferent BDNF Is Disrupted by Synucleinopathy and Partially Restored by STN DBS
Preclinical studies show a link between subthalamic nucleus (STN) deep brain stimulation (DBS) and neuroprotection of nigrostriatal dopamine (DA) neurons, potentially through brain-derived neurotrophic factor (BDNF) signaling. However, the question of whether DBS of the STN can be disease-modifying...
Autores principales: | Miller, Kathryn M., Patterson, Joseph R., Kochmanski, Joseph, Kemp, Christopher J., Stoll, Anna C., Onyekpe, Christopher U., Cole-Strauss, Allyson, Steece-Collier, Kathy, Howe, Jacob W., Luk, Kelvin C., Sortwell, Caryl E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Society for Neuroscience
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7939095/ https://www.ncbi.nlm.nih.gov/pubmed/33472823 http://dx.doi.org/10.1523/JNEUROSCI.1952-20.2020 |
Ejemplares similares
-
BDNF provides many routes toward STN DBS‐mediated disease modification
por: Fischer, D. Luke, et al.
Publicado: (2018) -
Quality Over Quantity: Advantages of Using Alpha-Synuclein Preformed Fibril Triggered Synucleinopathy to Model Idiopathic Parkinson’s Disease
por: Duffy, Megan F., et al.
Publicado: (2018) -
Impact of age and vector construct on striatal and nigral transgene expression
por: Polinski, Nicole K, et al.
Publicado: (2016) -
Effects of antidromic and orthodromic activation of STN afferent axons during DBS in Parkinson's disease: a simulation study
por: Kang, Guiyeom, et al.
Publicado: (2014) -
Genetic silencing of striatal CaV1.3 prevents and ameliorates levodopa dyskinesia
por: Steece‐Collier, Kathy, et al.
Publicado: (2019)